Pfizer (PFE) had its best month between September 5, 2023 and September 5, 2025 in July 2024, returning 10.8%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Pfizer (PFE) | September 2023 | -7.76% |
Pfizer (PFE) | October 2023 | -7.25% |
Pfizer (PFE) | November 2023 | 1.05% |
Pfizer (PFE) | December 2023 | -0.62% |
Pfizer (PFE) | January 2024 | -4.82% |
Pfizer (PFE) | February 2024 | -1.99% |
Pfizer (PFE) | March 2024 | 3.43% |
Pfizer (PFE) | April 2024 | -7.71% |
Pfizer (PFE) | May 2024 | 10.49% |
Pfizer (PFE) | June 2024 | -2.37% |
Pfizer (PFE) | July 2024 | 10.81% |
Pfizer (PFE) | August 2024 | -5.57% |
Pfizer (PFE) | September 2024 | 1.01% |
Pfizer (PFE) | October 2024 | -2.58% |
Pfizer (PFE) | November 2024 | -6.54% |
Pfizer (PFE) | December 2024 | 1.76% |
Pfizer (PFE) | January 2025 | 0.78% |
Pfizer (PFE) | February 2025 | 0.49% |
Pfizer (PFE) | March 2025 | -3.91% |
Pfizer (PFE) | April 2025 | -3.48% |
Pfizer (PFE) | May 2025 | -1.49% |
Pfizer (PFE) | June 2025 | 2.97% |
Pfizer (PFE) | July 2025 | -2.42% |
Pfizer (PFE) | August 2025 | 6.27% |
Pfizer (PFE) | September 2025 | -0.77% |
